Skip to main content
All
Stories
Press Releases
Documents
Events
Updates
Other
Press shift tab to select search category
Loading...
Careers
< Back
Careers
Careers
Working at Ipsen
Culture
All
Stories
Press Releases
Documents
Events
Updates
Other
Press shift tab to select search category
X
Loading...
EN
Ελληνικά
EL
English
EN
Greece
<
Global
EN
FR
Annual Report
EN
FR
Americas
Asia Pacific
Europe
Middle East & Africa
United States
Brazil
Canada
Mexico
Australia
China
Singapore
South Korea
Japan
Belgium
Ukraine
UK
Germany
France
Nordics
Greece
Italy
Netherlands
Spain
Poland
Russia
Czech Republic
Switzerland
Austria
UAE & Gulf
Saudi Arabia
Home
Company
< Back
Company
Company
History
Fondation Ipsen
Science
< Back
Science
Oncology
Rare Disease
Neuroscience
Products
Sustainability
< Back
Sustainability
Sustainability
Environment
Patients
People
Governance
Patients
< Back
Patients
Patients
Together for Oncology
Together for Rare Disease
Together for Neuroscience
Lay Summaries
Collaborate with us
Our Stories
< Back
Our Stories
Our Stories
CSR
Our People
Patient Centricity
Useful Links
Post navigation
Previous
Next
Somatuline Autogel®(lanreotide acetate)
Somatuline Autogel®(lanreotide acetate)
-
04 March 2024
-
0 mins read
Post navigation
Previous
Next
X
You are now leaving Ipsen Greece website.To continue, please click on
Continue
?